Combination therapies for inhibiting integrin-extracellular matrix interactions

Details for Australian Patent Application No. 2006283174 (hide)

Owner Cell Matrix

Inventors Freimark, Bruce; Van, Epps Dennis; Brooks, Peter C.

Agent Shelston IP

Pub. Number AU-A-2006283174

PCT Pub. Number WO2007/024921

Priority 60/711,060 24.08.05 US

Filing date 22 August 2006

Wipo publication date 1 March 2007

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

13 March 2008 PCT application entered the National Phase

  PCT publication WO2007/024921 Priority application(s): WO2007/024921

5 June 2008 Alteration of Name

  The name of the applicant has been altered to Cell-Matrix, Inc.

22 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006283175-Immunosuppressant compounds and compositions

2006283170-Highly photocatalytic phosphorusdoped anatase-TiO2 composition and related manufacturing methods